Nanogen – Nanogen, Inc. 6.25% Senior Convertible Notes Due 2010 (August 27th, 2007)
This Security shall be deemed to be a contract made under the laws of the State of New York, and for all purposes shall be construed in accordance with and governed by the laws of said State.
Nanogen – FIRST SUPPLEMENTAL INDENTURE Dated as of August 27, 2007 (August 27th, 2007)
FIRST SUPPLEMENTAL INDENTURE, dated as of August 27, 2007, ("First Supplemental Indenture") between Nanogen, Inc., a corporation duly organized and existing under the laws of the State of Delaware, as Issuer (the "Company"), having its principal office at 10398 Pacific Center Court, San Diego, California 92121, and The Bank of New York Trust Company, N.A., a national banking association, as Trustee (in such capacity, the "Trustee").
Nanogen – Nanogen, Inc., Issuer and the Bank of New York Trust Company, N.A., Trustee Indenture Dated as of August 27, 2007 DEBT SECURITIES (August 27th, 2007)
Indenture, dated as of August 27, 2007 between Nanogen, Inc., a corporation duly organized and existing under the laws of the state of Delaware (the Company), and The Bank of New York Trust Company, N.A., a national banking association (herein called the Trustee).
Nanogen – Amended and Restated Employment Agreement (February 23rd, 2007)
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this Agreement), dated February 19, 2007 is made by and between NANOGEN, INC., a Delaware corporation (hereinafter the Company), and Robert Saltmarsh (hereinafter Executive) and shall, except as otherwise provided herein, be effective as of January 1, 2007 (the Effective Date).
Nanogen – Securities Purchase Agreement (February 5th, 2007)
This Securities Purchase Agreement (this Agreement) is dated as of February 5, 2007, among Nanogen, Inc., a Delaware corporation (the Company), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a Purchaser and collectively the Purchasers).
Nanogen – February 5, 2007 Nanogen, Inc. 10398 Pacific Center Court San Diego, CA 92121 Thank You for the Opportunity to Work With You and Your Company, Nanogen, Inc. (February 5th, 2007)
This letter agreement (the Agreement) confirms that Nanogen, Inc. (Client) has engaged Ascendiant Securities, LLC (Ascendiant) to act on a best efforts basis as financial advisor and non-exclusive placement agent for the Client in connection with the structuring, issuance, and sale (the Transaction(s)) of equity securities (the Securities) for financing purposes. Ascendiant Securities, LLC is an investment banking firm registered as a broker-dealer with the U.S. Securities and Exchange Commission (SEC), and member of the NASD and SIPC.
Nanogen – Royalty Interest Assignment Agreement (November 9th, 2006)
WHEREAS Assignor is a party to a Second Amended and Restated Collaboration, License and Supply agreement with Applera Corporation (the Licensee) dated as of August 17, 2000, as amended by the First Side Agreement dated October 31, 2001, the Amendment No. 1 to the Second Amended and Restated Collaboration, License and Supply Agreement dated July 26, 2002 and Amendment No. 2 to the Second Amended and Restated Collaboration, License and Supply Agreement dated as of December 31, 2005 (as amended, the License Agreement);
Nanogen – Security Agreement (November 9th, 2006)
THIS SECURITY AGREEMENT is made as of the 29th day of September, 2006 between Drug Royalty Trust 9, a Delaware trust acting through its manager (Secured Party), located in care of Drug Royalty Corporation Inc. in its capacity as manager, at Royal Bank Plaza, Suite 3120, South Tower, Box 122, 200 Bay Street, Toronto, ON M5J 2J3, Canada, and Epoch Biosciences, Inc., a corporation organized and existing under the laws of the State of Delaware (Debtor), with its principal executive offices at 10398 Pacific Center Court, San Diego, CA 92121.
Nanogen – 2006 Executive Officer Incentive Compensation Plan (March 16th, 2006)
The 2006 Executive Officer Incentive Compensation Plan is based on the achievement of defined goals as approved by the Compensation Committee of the Board of Directors. These goals include Corporate goals and in some cases, may include goals that related directly to an individuals area of responsibility. There is no discretionary component of the Plan.
Nanogen – Employment Agreement (January 11th, 2005)
THIS EMPLOYMENT AGREEMENT (this Agreement), dated December 20, 2004, is made by and between NANOGEN, INC., a Delaware corporation (hereinafter the Company), and Robert Saltmarsh, (hereinafter Executive).